{
  "id": "cluster_2_doc4",
  "content": "Clinical trial NCT05677189 recruiting patients with seronegative arthropathies at Pacific Arthritis Center. Inclusion requires failed conventional DMARDs and elevated CRP (>10mg/L). Study compares IL-17 inhibitor sequencing strategies. Insurance coverage available through VBC-7741 participants with Prior Auth #PA-series.",
  "metadata": {
    "format": "research_note"
  }
}